NUWELLIS INC (NUWE)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.78+6.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NUWE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 9.0 | 8.3 | 8.7 | 8.9 | 8.5 | 7.9 | 7.4 | 5.5 | 5.0 | 3.6 | 1.3 | 0.1 | 0.3 | 0.1 | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 3.6 | 1.3 | 0.1 | 0.3 | 0.1 | 0.0 |
| Cost of Revenues | 2.7 | 3.1 | 3.1 | 3.9 | 3.8 | 3.4 | 3.4 | 2.7 | 3.7 | — | — | — | — | — | — |
| Gross Profit | 6.3 | 5.1 | 5.7 | 5.0 | 4.8 | 4.5 | 4.1 | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||
| Selling, General & Admin | 15.0 | 13.5 | 13.5 | 17.2 | 17.6 | 19.0 | 17.4 | 16.3 | 15.3 | 10.2 | 8.1 | 8.3 | 9.2 | 9.4 | 6.9 |
| R&D Expenses | 4.2 | 2.7 | 3.2 | 5.4 | 4.3 | 5.0 | 3.7 | 4.7 | 3.1 | 1.5 | 8.1 | 17.7 | 16.9 | 13.5 | 8.0 |
| Operating Income | (12.9) | (11.1) | (11.0) | (17.6) | (17.2) | (19.5) | (17.0) | (18.1) | (17.0) | (14.8) | (15.7) | (26.0) | (25.8) | (22.9) | (14.9) |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | 0.5 | 0.7 | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | 0.0 | (0.0) | (0.0) | (0.1) | — |
| EBT, Incl. Unusual Items | (11.3) | (17.5) | (11.2) | (20.2) | (14.5) | (19.5) | (15.8) | (18.1) | (17.0) | (13.4) | (15.8) | (26.7) | (25.8) | (23.0) | (14.8) |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.1) | (0.1) | (0.2) | (1.2) | (0.8) |
| Net Income | |||||||||||||||
| Net Income | (11.3) | (17.5) | (11.2) | (20.2) | (14.5) | (19.6) | (15.8) | (18.1) | (17.0) | (13.4) | (17.7) | (26.6) | (25.6) | (21.8) | (14.1) |
| Per Share | |||||||||||||||
| Basic EPS | (62.47) | (25.39) | (8.41) | (360.06) | (83.55) | (285.36) | (10.67) | — | — | — | — | — | — | — | — |
| Diluted EPS | (62.47) | (25.39) | (8.41) | (360.06) | (83.55) | (285.36) | (10.67) | — | — | — | — | — | — | — | — |
| Revenue per Share | 49.73 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.2 | 0.7 | 1.3 | 0.1 | 0.2 | 0.1 | 1.6 | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 0.2 | 0.7 | 1.3 | 0.1 | 0.2 | 0.1 | 1.6 | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||
| EBITDA | — | (10.9) | (10.7) | (17.3) | (16.8) | (19.0) | (16.7) | (17.9) | (16.8) | (14.0) | (15.2) | (25.6) | (25.5) | (22.7) | (14.7) |
| EBIT | (12.9) | (11.1) | (11.0) | (17.6) | (17.2) | (19.5) | (17.0) | (18.1) | (17.0) | (14.8) | (15.7) | (26.0) | (25.8) | (22.9) | (14.9) |
| Effective Tax Rate | — | — | — | -0.0% | -0.1% | -0.0% | -0.1% | -0.0% | -0.0% | -0.0% | 0.3% | 0.5% | 1.0% | 5.3% | 5.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.